News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Daily News CRT 2020 Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease Michael O'Riordan March 04, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2020 Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI Michael O'Riordan February 24, 2020
News Conference News CRT 2020 Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs Michael O'Riordan February 24, 2020
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News CRT 2018 Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT Michael O'Riordan March 08, 2018